Temozolomide 100 mg Capsule bulk supplier for pharma manufacturers

Temozolomide 100 Mg Capsule Suppliers & Bulk Manufacturers

Available Forms: Capsule and Powder for reconstitution

Available Strengths: Capsule( 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg); Powder( 100 mg/vial)

Reference Brands: Temodar(US), Temodal (EU)

emozolomide (Temodar/Temodal) is an oral chemotherapy drug used to treat glioblastoma and anaplastic astrocytoma. Approved in the US and EU, it’s available in 5–250 mg capsules and 100 mg IV form. Trusted by oncology specialists, it offers high bioavailability and compliance. Ideal for B2B pharma sourcing, licensing, or bulk supply.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Temozolomide (Temodar/Temodal) is a potent oral alkylating chemotherapy agent used in the treatment of glioblastoma multiforme and anaplastic astrocytoma. Approved by the FDA (as Temodar) and EMA (as Temodal), it is available in capsule strengths of 5 mg to 250 mg and as a 100 mg injectable vial for IV use. Widely used in neuro-oncology protocols, Temozolomide offers excellent bioavailability and treatment compliance. Multiple generic versions are available from trusted global manufacturers. Ideal for pharmaceutical B2B partners in the US and EU seeking reliable oncology portfolio expansion. Contact us for bulk API supply, licensing, or third-party manufacturing.

Temozolomide 100 Mg Capsule — third party manufacturing & bulk supply

Temozolomide 100 Mg Capsule is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Temozolomide 100 Mg Capsule is supplied as Capsule and Powder for reconstitution — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Temozolomide 100 Mg Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Temozolomide 100 Mg Capsule →

Back to Listing

Frequently Asked Questions

Temozolomide is an antineoplastic (anti-cancer) medicine used primarily for the treatment of certain brain cancers, including glioblastoma multiforme and anaplastic astrocytoma. It works by damaging the DNA of cancer cells, which inhibits their ability to multiply and causes cell death. Temozolomide is often used in combination with radiotherapy or as maintenance therapy to improve treatment outcomes.

Temozolomide is made from the active pharmaceutical ingredient temozolomide, an oral alkylating agent that belongs to the imidazotetrazine class of chemotherapeutic drugs.

The main trade name is Temodar. Other regional brand names include Temodal and Temcad.

Temodar was originally developed and marketed by Merck & Co. Generic versions are manufactured by various pharmaceutical companies worldwide.

The generic name is temozolomide.

Brand names include Temodar, Temodal, and Temcad, along with multiple regional generics.

Temozolomide is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, India, and other countries depending on the manufacturer and marketing authorization holder.